AFP and intrahepatic cholangiocarcinoma: Cirrhosis was more common in the HCC group (48.9% vs 28.2% in ICC lesions), whereas the serum tumor marker of CA19-9 was higher in the ICC patients (35.5% vs 21.6% in HCC lesions, p=0.003), while AFP was significantly lower in ICC than in HCC (P=0.005).